BioSpace News Archive

The global endoscopy devices market is expected to cross the value of US$ 42.8 Bn by the end of 2030.

The coronavirus pandemic has put intense strains on hospitals and clinics across the globe, both operationally & financially.

According to Report Study, the pressure ulcer diagnostics market is projected to cross US$ 1.49 Bn by 2031.

According to Nova One Advisor, The U.S. Topical Pain Relief market size was valued at US$ 2,812 million in 2021 and is expected to hit US$ 3,472 million by 2030, growing at a compound annual growth rate (CAGR) of 4.7% from 2022 to 2030.

Horizon Technology Finance Corporation (NASDAQ: HRZN) (“HRZN” or the “Company”), today provided its portfolio update for the second quarter ended June 30, 2022 and an update on the lending platform (“Horizon Platform”) of Horizon Technology Finance Management LLC (“HTFM”), its investment adviser.

AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its second quarter 2022 financial results before the opening of the financial markets on Tuesday, August 9, 2022.

CooperCompanies announced that consistent with the plan approved by its board of directors to pay annual dividends, the Company declared a semi-annual dividend of 3 cents per share, payable on August 11, 2022, to stockholders of record on July 27, 2022.

Azenta, Inc. (Nasdaq: AZTA) today reported preliminary results for its third fiscal quarter ended June 30, 2022.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the second quarter 2022 after market close on Thursday, August 4, 2022.

Veracyte, Inc. (Nasdaq: VCYT) announced that new data published today in PLOS ONE show that the company’s Percepta Genomic Sequencing Classifier (GSC) is highly accurate in re-classifying lung cancer risk among patients with lung nodules whose bronchoscopy results are inconclusive.